Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesShould Patients with High-Risk Soft Tissue Sarcoma Receive Adjuvant Chemotherapy
The Oncologist, 10/28/09
Schuetze SM et al. – In multiple analyses, patients with high–risk soft tissue sarcoma treated with chemotherapy have a >10% absolute lower risk for disease recurrence and longer disease–specific survival than patients treated without chemotherapy. In the absence of conclusive results from an adequately powered, randomized, controlled clinical trial, the available data support the use of chemotherapy in the management of high–risk, localized, soft tissue sarcoma.
Related Articles
Pathology of Soft Tissue Sarcomas
Clinical Oncology, 10/07/09
Relevance Score: 83%
Harmonizing adult and pediatric approaches to the treatment of soft-tissue sarcoma
Expert Review of Anticancer Therapy, 11/12/09
Relevance Score: 82%
Expression of M-CSF and CSF-1R Is Correlated with Histological Grade in Soft Tissue Tumors
Anticancer Research, 11/10/09
Relevance Score: 82%
Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: An exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG)
European Journal of Cancer, 10/29/09
Relevance Score: 82%
Alveolar soft-part sarcoma of the tongue in a 17-month-old
ENT Journal, 10/19/09
Relevance Score: 82%
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Sorafenib, a dual Raf kinase/vascular endothelial growth factor receptor inhibitor has significant anti-myeloma activity and synergizes with common anti-myeloma drugs
Oncogene, 11/25/09
Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients with solid tumors
Investigational New Drugs, 11/25/09
Adding more content to screening: reactivation of FOXO as a therapeutic strategy
Clinical and Translational Oncology, 11/25/09
Today in Soft Tissue/Sarcoma...keeping you current
Receive free subspecialty "5-minute updates" via email
The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES)
Cancer, 11/25/09
Soft tissue tumors associated with EWSR1 translocation
Virchows Archiv, 11/25/09
Randomized Trial and Pharmacokinetic Study of Pegfilgrastim versus Filgrastim after Dose-Intensive Chemotherapy in Young Adults and Children with Sarcomas
Clinical Cancer Research, 11/20/09
Sponsor
Article Search
Sponsor
Sponsor